Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CETCO, a subsidiary of Minerals Technologies Inc., is a global leader in the development and manufacture of high-performance mineral-based technologies for diverse industries, including healthcare and life sciences. Within its healthcare segment, the company specializes in high-purity smectite clays and bentonite derivatives used as active pharmaceutical ingredients (APIs) and excipients. These materials are primarily utilized in the formulation of anti-diarrheal medications, gastrointestinal treatments, and topical dermatological products. CETCO's expertise in mineral science allows it to provide specialized solutions for drug delivery and toxin sequestration, supporting both human and animal health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CETCO.